HIF1A and systemic sclerosis: The present study was designed to verify whether hypoxia induces the EndMT in the pathogenesis of SSc that is dependent on HIF-1α/VEGF signaling, which may represent an important and novel therapeutic target for the complications of SSc–associated fibroproliferative vasculopathy and fibrosis.